Comments

CG Oncology Stock Price, Quotes and Forecasts

Q: What sector and industry does CG Oncology (CGON) operate in?

CG Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CGONNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$24.49

-1.93-7.31%

At close: -

$24.49

0.000.00%

After Hours: 4:36 PM EDT

Q4 2024 Earnings were released on Fri Mar 28th, before the market open

CG Oncology (CGON) Forecast

News Earnings CG Oncology (CGON) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

CG Oncology Stock Price, Quotes and Forecasts | NASDAQ:CGON | Benzinga

Explore CG Oncology stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CGON.

Open	$26.82
Close	$24.49
Volume / Avg.	1.26M / 647.82K
Day Range	$23.92 - $26.82
52 Wk Range	23.91 - 46.99
Market Cap	$1.86B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	9.58%
Days to Cover	9.89

Recent News

ImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug

HC Wainwright initiates coverage on ImmunityBio with a Buy rating, citing Anktiva's growth potential. The firm projects $4.3 billion in sales, up from $137M in 2025.

Vandana Singh

Why CG Oncology (CGON) Stock Is Down 9%

CG Oncology shares are trading lower by 9.2% during Wednesday's session. The company announced it filed an underwritten public offering of 7.3 million shares of its common stock.

Henry Khederian

CG Oncology Touts Encouraging Data From Late-Stage Study Of Bladder Cancer Candidate

CG Oncology's BOND-003 trial reveals durable efficacy of cretostimogene in NMIBC patients, with median DOR exceeding 27 months and no severe side effects.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$26.82
Close	$24.49
Volume / Avg.	1.26M / 647.82K
Day Range	$23.92 - $26.82
52 Wk Range	23.91 - 46.99
Market Cap	$1.86B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	9.58%
Days to Cover	9.89

About Cg Oncology Inc.

Sector

Health Care

Industry

Biotechnology

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commerc...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy CG Oncology (CGON) stock?

You can purchase shares of CG Oncology (NASDAQ:CGON) through any online brokerage.

View our list of the best stock brokerages

Who are CG Oncology (CGON) competitors?

Other companies in CG Oncology’s space includes: Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), Centessa Pharmaceuticals (NASDAQ:CNTA), Ascentage Pharma Group (NASDAQ:AAPG) and Arcutis Biotherapeutics (NASDAQ:ARQT).

What is the forecast, or price target, for CG Oncology (CGON) stock?

CG Oncology has a consensus price target of $65.11.

What is the current price for CG Oncology (CGON)?

The stock price for CG Oncology (NASDAQ: CGON) is $24.49 last updated March 31, 2025 at 4:36 PM EDT.

Does CG Oncology (CGON) pay a dividend?

There are no upcoming dividends for CG Oncology.

When is CG Oncology (NASDAQ:CGON) reporting earnings?

CG Oncology’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is CG Oncology (CGON) going to split?

There is no upcoming split for CG Oncology.

What sector and industry does CG Oncology (CGON) operate in?

CG Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.